Takeda Pharmaceutical (TAK) earnings

Earnings (net income) · fiscal 2026
-¥152.39B

Takeda Pharmaceutical (TAK) reported net income of -¥152.39B in fiscal 2026 (the year ended March 31, 2026). In fiscal 2025 the figure was ¥107.93B. Figures as of 18 Nov 2026, 05:36 UTC, from Yahoo Finance.

Key facts

Earnings (net income), fiscal 2026
-¥152.39B
Highest on record
¥317.02Bfiscal 2023
Lowest on record
-¥152.39Bfiscal 2026
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in JPY. Figures, not advice.

Takeda Pharmaceutical earnings, in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ¥317.02B in fiscal 2023 and the lowest -¥152.39B in fiscal 2026.

History · 4 fiscal years

Earnings (net income) by fiscal year

Takeda Pharmaceutical earnings, year by year

Takeda Pharmaceutical (TAK) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2026-¥152.39B 241.2% down
2025¥107.93B 25.1% down
2024¥144.07B 54.6% down
2023¥317.02B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical earnings: questions and answers

What is Takeda Pharmaceutical's net income?

Takeda Pharmaceutical (TAK) reported net income of -¥152.39B in fiscal 2026 (the year ended March 31, 2026). In fiscal 2025 the figure was ¥107.93B.

What are the highest and lowest net income figures on record for Takeda Pharmaceutical?

Across the 4 fiscal years on record (2023–2026), the highest was ¥317.02B in fiscal 2023 and the lowest -¥152.39B in fiscal 2026.

How is Takeda Pharmaceutical's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/TAK/earnings

Underlying data: Yahoo Finance.